Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)
Clinical trial NCT04385290 · RECRUITING
Trial details
- NCT number
- NCT04385290
- Sponsor
- Technische Universität Dresden
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-04
- Primary completion
- 2027-04-01
- Enrollment
- 214
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.